Sep 22 | Mar 22 | Sep 21 | Mar 21 | Sep 20 | |
---|---|---|---|---|---|
Income Statement | - | ||||
Total Revenue | - | - | - | - | - |
Gross Profit | - | - | - | - | - |
EBIT | - | - | - | - | - |
EBITDA | - | - | - | - | - |
Net Income Common Stockholders | - | - | - | - | - |
Balance Sheet | - | ||||
Cash, Cash Equivalents and Short-Term Investments | $ ― | $ ― | $ ― | $ ― | $ ― |
Total Assets | $ 39.41M | $ 43.13M | $ 69.92M | $ 55.59M | $ 42.38M |
Total Debt | $ ― | $ ― | $ ― | $ ― | $ ― |
Net Debt | $ ― | $ ― | $ ― | $ ― | $ ― |
Total Liabilities | $ 2.69M | $ 2.13M | $ 4.92M | $ 2.94M | $ 173.00K |
Stockholders Equity | $ 36.72M | $ 41.01M | $ 65.01M | $ 52.66M | $ 42.21M |
Cash Flow | - | ||||
Free Cash Flow | - | - | - | - | - |
Operating Cash Flow | - | - | - | - | - |
Investing Cash Flow | - | - | - | - | - |
Financing Cash Flow | - | - | - | - | - |